The pertussis syndrome: a persistent problem.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001049:Apnea / Q000209:etiology; D001427:Bacterial Toxins / Q000096:biosynthesis; D001886:Bordetella pertussis / Q000502:physiology; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002648:Child; D004168:Diphtheria Toxoid / Q000009:adverse effects; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D004338:Drug Combinations / Q000009:adverse effects; D005455:Fluorescent Antibody Technique; D006801:Humans; D007116:Immunization, Passive; D007223:Infant; D009422:Nervous System Diseases / Q000209:etiology; D010567:Pertussis Vaccine / Q000009:adverse effects; D011014:Pneumonia / Q000209:etiology; D012640:Seizures / Q000209:etiology; D013256:Steroids / Q000627:therapeutic use; D013577:Syndrome; D013745:Tetanus Toxoid / Q000009:adverse effects; D014611:Vaccination; D010566:Virulence Factors, Bordetella; D014917:Whooping Cough / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy
D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D001993:Bronchodilator Agents; D004168:Diphtheria Toxoid; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D004338:Drug Combinations; D010567:Pertussis Vaccine; D013256:Steroids; D013745:Tetanus Toxoid; D010566:Virulence Factors, Bordetella